跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
B-8
首页
药物
B-8
B-8
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
EP 4309736 A3
申请人: GILEAD SCIENCES INC
优先权: 2014
EP
US
WO
11 件公开
Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US 2012225922 A1
申请人: MACCECCHINI MARIA
优先权: 2011
CN
US
9 件公开
Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
US 8198279 B2
申请人: SPRINGER CAROLINE JOY
优先权: 2008
US
9 件公开
Process for production of optically active amine derivatives
US 8097737 B2
申请人: URAYAMA SHINICHI
优先权: 2004
CN
EP
US
8 件公开
SODIUM (2R, 5S, 13AR) -7, 9-DIOXO-10- ( (2,4,6-TRIFLUOROBENZYL) CARBAMOYL) -2, 3, 4, 5, 7, 9, 13, 13A-OCTAHYDRO-2, 5-METHANOPYRIDO [1',2' : 4.5] PYRAZINO [2, 1-B] OXAZEPIN-8-OLATE
EP 4523758 A3
申请人: GILEAD SCIENCES INC
优先权: 2014
CN
EP
US
6 件公开
5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-D] PYRROLO [3, 2-B] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5
EP 4688785 A1
申请人: BEONE MEDICINES I GMBH
优先权: 2023
CN
EP
WO
5 件公开
SOLID FORMS OF POSIPHEN D-TARTRATE
EP 4731205 A2
申请人: ANNOVIS BIO INC
优先权: 2023
CN
EP
US
WO
4 件公开
2,6-DIMETHYL-N-((PYRIDIN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N-[(PYRIDIN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS
EP 3864017 C0
申请人: CUROVIR AB
优先权: 2018
EP
US
WO
4 件公开
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
US 8044204 B2
申请人: ACHILLION PHARMACEUTICALS INC
优先权: 2006
US
4 件公开
Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
US 7902365 B2
申请人: ACHILLION PHARMACEUTICALS INC
优先权: 2007
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈